. Ciliary loss of Gpr161 depends on its signaling activity and direct binding to β-arrestins. (A) Stable T-REx-293 cells expressing CAM YEL (conformation-based cAMP BRET biosensor) and inducibly coexpressing untagged mouse Gpr161 were treated with 4 µg/ml doxycycline (Dox) for 12 h. The media was replaced with assay buffer containing 1 mM IBMX 45 min before the experiment. Readings were taken using 475-and 535-nm emission filters simultaneously after the addition of 5 µM coelenterazine-h. After tracking the baseline BRET ratio for 2 min, cells were treated with drugs (10 µM each) or 10 µM Forskolin using injectors (indicated by arrow). Oxysterols used were as follows: 7-keto-27-hydroxycholesterol, a naturally occurring oxysterol (Myers et al., 2013) , 20α-hydroxycholesterol, a synthetic oxysterol (Nachtergaele et al., 2012) , and 7α,25-dihydroxycholesterol, which is an agonist for Gpr183 (Hannedouche et al., 2011) . The BRET ratios were subsequently quantified for 5 min. Mean values of two independent experiments are represented graphically. (B) Confluent NIH 3T3 Flp-In cells stably expressing GFP-tagged WT Gpr161 were starved for a total of 24 h and treated with SAG (500 nM) for indicated time periods before fixation. Fixed cells were processed for immunofluorescence with anti-GFP and anti-acetylated tubulin antibodies, for detecting GFP-positive cilia. Data represents mean ± SD from two experiments. (C and D) Confluent NIH 3T3 Flp-In cells stably expressing GFP-tagged full-length Gpr161 V158E mutant (VE) were starved ±1 µM SAG for 24 h, and Gpr161 (C) and Smo (D) levels in cilia were determined by immunofluorescence. For C, GFP ciliary intensities in cilia were quantified using ImageJ (n = 50 each; *, P < 0.01). For D, data represent mean ± SD from three separate fields from one experiment (*, P < 0.001 with respect to untreated cells in each cell line). (E) Confluent NIH 3T3 Flp-In cells stably expressing indicated constructs were starved for 30 h, and immunoblotted for indicated proteins (Materials and methods). Relative transcript levels for Gpr161 GFP were determined in parallel by qRT-PCR (mean ± SD). (F) Confluent IMCD3 Flp-In cells were starved for 24 h and treated with ±250 nM SAG for the last 90 min. β-arrestin localization to cilia is shown after immunofluorescence with anti-pan-β-arrestin and acetylated tubulin (AcTub) antibodies. Bar, 5 µm. (G and H) Confluent WT and β-arrestin1/2 double-knockout MEFs (Arrb1/2) were starved for 48 h, treated with 500 nM SAG for the indicated time points before fixation, and processed for immunofluorescence using anti-Gpr161 and anti-acetylated tubulin antibodies to quantify cilia positive for Gpr161 by microscopy. Data represent mean ± SD from three independent experiments. *, P < 0.001, with respect to untreated WT cells. (I) Confluent NIH 3T3 Flp-In cells stably expressing GFP-tagged Gpr161 Δ376 mutant were starved for 24 h ±1 µM SAG before fixation, and immunostained using anti-GFP/anti-Smo and anti-acetylated tubulin antibodies. Data represent mean ± SD from two independent experiments for Gpr161 IF, and three separate fields from one experiment for Smo IF. *, P < 0.001 with respect to untreated cells. Figure S2 . Steady-state localization of Gpr161 in cilia is not controlled by Shh pathway activity. (A-D) Confluent WT, Smo −/− , Ptch1 −/− , or Sufu −/− MEFs were serum starved for 48 h, treated with 500 nM SAG or 300 ng/ml octyl-Shh for the last 24 h before fixation, and immunostained using anti-Gpr161 (green) and anti-acetylated tubulin (AcTub; red) antibodies. Bar, 5 µm. (E) Confluent WT and Sufu −/− MEFs were serum starved for 48 h, treated with 500 nM SAG for the last 24 h before fixation, and immunostained using anti-Ptch1 (green) and anti-acetylated tubulin (AcTub; red) antibodies. Bar, 5 µm. Figure S3 . Presence of activated Smo in cilia determines steady-state levels of Gpr161. (A) Confluent WT MEFs were serum starved for 48 h, treated with drugs for last 24 h before fixation, and immunostained for Gpr161 (green) and acetylated tubulin (AcTub; red). Drugs used were as follows: 500 nM SAG, 1 µM KAAD-cyclopamine (KAAD), 1 µM GDC-0449 (GDC), 1 µM SANT1, and 5 µM cyclopamine (cyclo). Arrows and arrowheads indicate cilia positive and negative for Gpr161, respectively. Bar, 5 µm. (B) Confluent Ptch1 −/− MEFs were serum starved for 48 h, treated ±1 µM SANT1 for the last 24 h before fixation, and immunostained using anti-Gpr161 (green) and anti-acetylated tubulin (AcTub; red) antibodies. Bar, 5 µm. (C) Confluent WT and Dync2h1 lln/lln MEFs (Ocbina et al., 2011) were serum starved for 48 h, treated ±500 nM SAG for the indicated time periods before fixation, and immunostained using anti-Gpr161 (green) and anti-acetylated tubulin (red) antibodies to quantify Gpr161-positive cilia. N, total counted cilia from one experiment. (D) Confluent WT and β-arrestin1/2 double-knockout MEFs (Arrb1/2 ko) were serum starved for 48 h, treated ±1 µM SAG in starvation media for 36 h before fixation, and immunostained using anti-Smo (green) and anti-acetylated tubulin (AcTub; red) antibodies. Arrows and arrowheads indicate cilia positive and negative for Smo, respectively. (E) β-arrestin1/2 double-knockout MEFs were transfected with siRNAs against Gpr161 (Materials and methods). Confluent cells were starved for 24 h and further treated ±1 µM SAG for 30 h in starvation media. Total RNA was isolated, and Gli1 expression levels were determined by quantitative real-time RT-PCR. Percentages of Gpr161-positive cilia upon RNAi suggests partial knockdown of the receptor in the primary MEFs. Data represent mean ± SEM from three independent experiments. ***, P < 0.001. (F) SAG-pretreated IMCD3 cells ± KAAD-cyclopamine, as described in Fig. 3 F, were immunostained to detect ciliary Gpr161 levels. Arrowheads and arrows indicate cilia negative and positive for Gpr161, respectively. Bar, 10 µm. Figure S4 . Smo enhances recruitment of β-Arrestin to Gpr161. (A and B) T-REx 293 cells were cotransfected with a constant amount of Rluc-β-arrestin1/2 (donor) and increasing amounts of Gpr161-eYFP (acceptor), ±1 µg/well of a six-well plate untagged human Smo (10×), ±1 µg/well of a six-well plate Flag-D2R. Flag-D2R-transfected cells were also finally treated with 1 µM of the D2R agonist quinpirole for 20 min (A). The cells were incubated with 800 ng/ml pertussis toxin for 12 h before the BRET assays (B). Cells were subjected to BRET analysis (Materials and methods). The titration curves are mean ± SEM from three independent experiments (A) and mean ± SD from one experiment performed in duplicate (B). *, P < 0.05; **, P < 0.01 for BRET 50 values with respect to only Gpr161/β-arrestin2 cotransfected cells in A. (C) BRET assays for Gpr161-β-arrestin2 interactions as in Fig. 5 C with GRK2 knockout line 2 from two independent experiments (mean ± SD). *, P < 0.05; **, P < 0.01 with respect to Rluc-β-arrestin2 binding to Gpr161-eYFP. (D) IMCD3 cells transfected with ciliary-targeted Grk2 C-terminus fusion (CLS-mCherry-Grk2CT; Materials and methods) were starved ±500 nM SAG for 17 h and subjected to immunofluorescence for Gpr161 (green) and anti-acetylated tubulin (magenta). CLS-mCherry-Grk2CT positive (red) cilia were scored for Gpr161. Data represents mean ± SD from two experiments. ***, P < 0.001. (E) Pixel intensities of Smo in control or Grk2 siRNA-treated IMCD3 cilia ± SAG treatment represented graphically. n = 100 each; ****, P < 0.0001 with respect to untreated cells in each background. (F) IMCD3 cells with stable expression of Gpr161 vl VN155 I1522L were infected ± retroviruses expressing VC155-βArr2. After antibiotic selection, confluent cells were starved for 24 h before fixing and immunostained with anti-GFP (red) anti-acetylated tubulin (AcTub; magenta) antibodies. Intensities of eVenus complementation in the cilia (green channel) of GFP-positive cells (red channel) were quantified using ImageJ and represented graphically (right); n = 21 each. Bar, 5 µm. (G) IMCD3 cells were transfected with the indicated constructs (Materials and methods), starved for 17 h before fixing, and immunostained with anti-HA (red) anti-GFP (magenta) antibodies. Intensities of eVenus complementation in the cilia (green channel) of HA/GFP-positive cells were quantified using ImageJ and represented graphically (right); n ≥ 22 each. Bar, 5 µm. P < 0.001 between groups. Arrows and arrowheads indicate cilia positive and negative for eVenus complementation, respectively (F and G). Figure S5 . Disappearance of Gpr161 from cilia is dependent on clathrin-mediated endocytosis. (A) Confluent NIH 3T3 Flp-In cells stably expressing GFPtagged Gpr161 vl mutant were treated ±1 µM SAG for 24 h in starvation media before fixation, and Smo levels were quantified by immunofluorescence. Data represent mean ± SD from three separate fields from one experiment. **, P < 0.01 with respect to untreated cells. (B) Confluent NIH 3T3 Flp-In cells stably transfected with indicated constructs were starved for 30 h and immunoblotted for indicated proteins (Materials and methods). Relative transcript levels for Gpr161 GFP were determined in parallel by quantitative real-time RT-PCR (mean ± SD). (C and D) IMCD3 Flp-In cells were transfected with predesigned On-target Plus siRNAs against clathrin heavy chain (Chc) for 72 h. Confluent cells were starved for 30 h, treated ±250 nM SAG for 5 h before fixing, and immunostained using anti-Smo (green) and anti-acetylated tubulin (AcTub; red) antibodies to quantify cilia positive for Smo. Arrows and arrowheads indicate cilia positive and negative for Smo, respectively. Bar, 10 µm. Data represent mean ± SD from three separate fields from one experiment. *, P < 0.001; **, P < 0.0001 with respect to DMSO-treated cells in each case. (E) IMCD3 Flp-In cells transfected with indicated predesigned siRNAs for 72 h were starved for the last 24 h, fixed, and immunostained for CHC. CHC siRNA-treated cells show specificity of the anti-CHC antibody. Arrowheads denote cilia. Bar, 5 µm. (F) ARPE-19 cells reverse transfected with siRNAs against CHC were transfected with plasmids expressing CD8α-tagged with Gpr161 C tail or third intracellular loop (IC3) fragments (Materials and methods) the next day. Cells were subjected to ELI SA (Materials and methods). Endocytosed CD8α fusion proteins were expressed as a percentage of surface CD8 fusions. Inset shows immunoblot for CHC. Data represent mean ± SEM from three experiments. *, P < 0.05; **, P < 0.01 with respect to control siRNA-treated cells at respective time points. (G) Confluent NIH 3T3 cells stably expressing untagged codon-wobbled wild type or mutant Gpr161 (Materials and methods) were treated ±SAG in starvation media for 30 h, followed by RNA isolation and quantification of Gli1 levels by quantitative real-time RT-PCR. Data represent mean ± SEM from three separate stable lines in each background and one to four independent experiments for each line. Quantitative real-time RT-PCR confirmed Gpr161 overexpression to be identical between the respective lines (Materials and methods). *, P < 0.05.
